Approvals/TGA/EUG-IRINOTECAN irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial

Approved

STANDARD

EUG-IRINOTECAN irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial

Eugia Pharma (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: e78b573fb1dc7871
Product Name: EUG-IRINOTECAN irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial
Artg Id: 439200
Artg Name: EUG-IRINOTECAN irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial
Sponsor: Eugia Pharma (Australia) Pty Ltd
Company Detail Path: /organization/eugia-pharma-australia-pty-ltd
Artg Date: 2025-03-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

e78b573fb1dc7871

Type

Standard